Announcements Trials
Browse Landscape

Status

Completed 26Unknown 11Recruiting 4Enrolling by invitation 3Withdrawn 2Terminated 2Suspended 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Myeloid 1

Conditions

Neoplasms 69Breast Neoplasms 68Prostatic Neoplasms 48Lung Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Colorectal Neoplasms 19Pancreatic Neoplasms 17Carcinoma, Hepatocellular 16Brain Neoplasms 15Leukemia, Myeloid, Acute 14Lymphoma 13Colonic Neoplasms 13Carcinoma, Renal Cell 13Melanoma 12Head and Neck Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Ovarian Neoplasms 11Neoplasm Metastasis 10Lymphoma, Non-Hodgkin 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Multiple Myeloma 8Leukemia 8Glioblastoma 8Stomach Neoplasms 7Recurrence 7Papillomavirus Infections 7Hodgkin Disease 7

Interventions

Infliximab 1Etanercept 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Observational × Arthritis, Rheumatoid × Clear all
NCT02450396 2026-03-27

EGR2

Assistance Publique - Hôpitaux de Paris

Withdrawn
Myeloid

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

NCT00724672 2015-06-01

A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)

Merck Sharp & Dohme LLC

Withdrawn

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡